Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

A decrease in blood cholesterol after gastrostomy could impact survival in ALS

Abstract

Although the global benefits of gastrostomy have been proven in amyotrophic lateral sclerosis (ALS), the impact on biological parameters has not been explored yet. The aim of this preliminary work was to evaluate the modification of biological parameters in patients with ALS undergoing gastrostomy. We retrospectively collected clinical and biological data from 44 patients having undergone gastrostomy at three time points (T0, T1 and T2: before, at the time of and after gastrostomy). We examined the relationship between the biological parameters and disease progression. Variations of the concentrations of total cholesterol significantly differed before (T1–T0) vs those after gastrostomy (T2–T1; P=0.0044). The variations of total cholesterol and low-density lipoprotein cholesterol concentrations after gastrostomy were negatively associated with survival (P=0.0002). This study showed for the first time that patients with ALS fed quite exclusively by gastrostomy had decreased blood cholesterol after gastrostomy. We suggest that a restoration of normal lipid metabolism should be planned in patients with ALS.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73: 1227–1233.

    Article  CAS  Google Scholar 

  2. Dorst J, Dupuis L, Petri S, Kollewe K, Abdulla S, Wolf J et al. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study. J Neurol 2015; 262: 849–858.

    Article  Google Scholar 

  3. Wills AM, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet 2014; 383: 2065–2072.

    Article  CAS  Google Scholar 

  4. Brooks BR, Miller RG, Swash M, Munsat TL . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293–299.

    Article  CAS  Google Scholar 

  5. Desport JC, Preux PM, Bouteloup-Demange C, Clavelou P, Beaufrere B, Bonnet C et al. Validation of bioelectrical impedance analysis in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 2003; 77: 1179–1185.

    Article  CAS  Google Scholar 

  6. Rafiq MK, Lee E, Bradburn M, McDermott CJ, Shaw PJ . Effect of lipid profile on prognosis in the patients with amyotrophic lateral sclerosis: insights from the olesoxime clinical trial. Amyotroph Lateral Scler Frontotemporal Degener 2015; 16: 478–484.

    Article  CAS  Google Scholar 

  7. Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, Bittar R et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 2008; 70: 1004–1009.

    Article  CAS  Google Scholar 

  8. Huang R, Guo X, Chen X, Zheng Z, Wei Q, Cao B et al. The serum lipid profiles of amyotrophic lateral sclerosis patients: a study from south-west China and a meta-analysis. Amyotroph Lateral Scler Frontotemporal Degener 2015; 16: 359–365.

    Article  Google Scholar 

  9. Nunes G, Santos CA, Grunho M, Fonseca J . Enteral feeding through endoscopic gastrostomy in amyotrophic lateral sclerosis patients. Nutr Hosp 2016; 33: 561.

    Article  Google Scholar 

Download references

Acknowledgements

Author contributions

HB, PC and PCou were involved in the conceptualisation and design of the study. OLT, SM and SB were involved in the acquisition of the data. Statistical analysis was conducted by HB and FP. HB wrote the first version of the manuscript. HB, PC, PCou, CRA, PV and VM were involved in the interpretation of data for the work and revised the manuscript critically for important intellectual content.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Blasco.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Blasco, H., Patin, F., Molinier, S. et al. A decrease in blood cholesterol after gastrostomy could impact survival in ALS. Eur J Clin Nutr 71, 1133–1135 (2017). https://doi.org/10.1038/ejcn.2017.54

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2017.54

Search

Quick links